loadpatents
Patent applications and USPTO patent grants for Neuromed Technologies, Inc..The latest application filed is for "calcium channel blockers comprising two benzhydril moieties".
Patent | Date |
---|---|
Nucleic acids encoding mammalian T-type calcium channels Grant 7,501,263 - Snutch , et al. March 10, 2 | 2009-03-10 |
Preferentially substituted calcium channel blockers Grant 7,064,128 - Snutch , et al. June 20, 2 | 2006-06-20 |
Calcium channel blockers comprising two benzhydril moieties App 20060084660 - Snutch; Terrance P. ;   et al. | 2006-04-20 |
Urea derivatives as calcium channel blockers App 20060063775 - Pajouhesh; Hassan ;   et al. | 2006-03-23 |
Diarylamine derivatives as calcium channel blockers App 20050227999 - Pajouhesh, Hassan ;   et al. | 2005-10-13 |
Calcium channel blockers comprising two benzhydril moieties Grant 6,951,862 - Snutch , et al. October 4, 2 | 2005-10-04 |
Calcium channel blockers comprising two benzhydril moieties Grant 6,949,554 - Snutch , et al. September 27, 2 | 2005-09-27 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine Grant 6,943,168 - Snutch , et al. September 13, 2 | 2005-09-13 |
N-type calcium channel blockers App 20050014748 - Pajouhesh, Hassan ;   et al. | 2005-01-20 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine App 20040044004 - Snutch, Terrance P. ;   et al. | 2004-03-04 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine App 20040034035 - Snutch, Terrance P. ;   et al. | 2004-02-19 |
Preferentially substituted calcium channel blockers Grant 6,617,322 - Snutch September 9, 2 | 2003-09-09 |
Partially saturated calcium channel blockers Grant 6,492,375 - Snutch December 10, 2 | 2002-12-10 |
Preferentially substituted calcium channel blockers Grant 6,387,897 - Snutch May 14, 2 | 2002-05-14 |
Fused ring calcium channel blockers Grant 6,310,059 - Snutch October 30, 2 | 2001-10-30 |
Calcium channel blockers Grant 6,011,035 - Snutch , et al. January 4, 2 | 2000-01-04 |
Pro-cytotoxic drug conjugates for anticancer therapy Grant 5,502,037 - Kondratyev March 26, 1 | 1996-03-26 |
SEC | 0001294709 | NeuroMed Technologies Inc |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.